Alain Cribier

Showing 1-8 of 8 articles

TAVI durability beyond five years: no alarms, but stay alert

Eltchaninoff H, Durand E, Cribier A

July 20, 2018 | 10.4244/EIJV14I4A67

Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition

Eltchaninoff H, Durand E, Avinee G, Tron C, Litzler P-Y, Bauer F, Dacher J-N, Werhlin C, Bouhzam N, Bettinger N, Candolfi P, Cribier A

June 14, 2018 | 10.4244/EIJ-D-18-00015

Interventions for valvular disease

Commemorating the 15-year anniversary of TAVI: insights into the early stages of development, from concept to human application, and perspectives

May 15, 2017 | 10.4244/EIJV13I1A3

Patient selection for TAVI in 2014: is it justified to treat low- or intermediate-risk patients? The cardiologist’s view

Cribier A, Durand E, Eltchaninoff H

September 27, 2014 | 10.4244/EIJV10SUA3

Historical perspective: 10th year anniversary of TAVI

September 30, 2012 | 10.4244/EIJV8SQA4

Aorto-iliac angiography as a screening tool in selecting patients for transfemoral aortic valve implantation with the Edwards SAPIEN bioprosthesis

Eltchaninoff H, Kerkeni M, Zajarias A, Tron C, Godin M, Sanchez Giron C, Baala B, Cribier A

September 30, 2009

Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, de Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Pierard L, Pomar J-L, Schofer J, Tornos P, Tuzcu ME, van Hout B, von Segesser L, Walther T

August 20, 2008

Five month study of percutaneous heart valves in the systemic circulation of sheep using a novel model of aortic insufficiency

Eltchaninoff H, Nusimovici-Avadis D, Babaliaros V, Spenser B, Felsen B, Cribier A

February 20, 2006

1

Latest news

CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR

Ahead of Print: Coronary Artery Thrombosis in COVID-19

Coronary collaterals, the natural grafts of CTO lesions

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

(The Trials book is supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

Intravascular ultrasound in PCI for in-stent CTO: guidance for long-term success

JM De la Torre Hernandez

This Week's JAA's: Real-world Use of the Evolut PRO Valve...

Valvular disease